SHENZHEN, China, Nov. 03, 2025 — UTime Limited (Nasdaq: WTO) today detailed its continuing investigation into health data analysis, specifically focusing on the prospective utilization of artificial intelligence (AI) technologies.
UTime is creating AI-powered algorithmic models designed to conduct comprehensive analysis of ongoing physiological data gathered from smart wearable devices, including watches and rings. Present areas of research involve: constructing models for evaluating hypertension risk through the integration of multi-parameter data such as blood pressure, heart rate, activity levels, and sleep; and performing trend evaluations of users’ cardiovascular system health by examining characteristics like pulse wave morphology. The company explicitly declares that all these AI analytical capabilities are meant to furnish users with insights into health trends and serve as references for risk management, and are not intended to replace professional medical diagnoses.
Mr. Hengcong Qiu, Chief Executive Officer of UTime Limited, commented, “The data itself is not the ultimate objective. Our research and development efforts are concentrated on extracting more profound insights from the data, assisting users in recognizing their personal health trends sooner. This represents the path of our sustained technological investment.”
Concerning UTime Limited
Operating under the NASDAQ ticker WTO, UTime Limited participates in the conceptualization, creation, manufacturing, distribution, and brand management of mobile devices both within China and worldwide. The corporation endeavors to supply budget-friendly products and caters to an extensive clientele.
Forward-Looking Statements Disclosure
This press release includes forward-looking statements as defined by Section 21E of the Securities Exchange Act of 1934, in its amended form. Any declarations that are not statements of historical fact are considered forward-looking. These declarations are subject to various known and unknown risks, uncertainties, and other elements that could lead to the Company’s actual outcomes, operational effectiveness, or accomplishments differing substantially from any future outcomes, performances, or achievements explicitly stated or suggested by such forward-looking statements. For further details on risk factors, please consult UTime Limited’s Annual Report on Form 20-F and its other filings with the SEC. Forward-looking statements are current only as of the date of this release. The Company bears no responsibility to publicly amend or revise any forward-looking statements, whether due to new data, subsequent events, or otherwise, unless mandated by pertinent law.
For Contact:
UTime Limited
7th Floor, Building 5A
Shenzhen Software Industry Base, Nanshan District
Shenzhen, People’s Republic of China 518061
Telephone: (86) 755 86512266
Supplemental Files
